AP2002002671A0 - Protease inhibitors. - Google Patents

Protease inhibitors.

Info

Publication number
AP2002002671A0
AP2002002671A0 APAP/P/2002/002671A AP2002002671A AP2002002671A0 AP 2002002671 A0 AP2002002671 A0 AP 2002002671A0 AP 2002002671 A AP2002002671 A AP 2002002671A AP 2002002671 A0 AP2002002671 A0 AP 2002002671A0
Authority
AP
ARIPO
Prior art keywords
disease
cartilage
compounds
protease inhibitors
matrix degradation
Prior art date
Application number
APAP/P/2002/002671A
Other languages
English (en)
Inventor
Robert Wells Marquis Jr
Yu Ru
Daniel Frank Veber
Maxwell David Cummings
Scott Kevin Thompson
Dennis Shinji Yamashita
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AP2002002671A0 publication Critical patent/AP2002002671A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
APAP/P/2002/002671A 2000-06-14 2001-06-14 Protease inhibitors. AP2002002671A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59384500A 2000-06-14 2000-06-14
PCT/US2001/019062 WO2001095911A1 (fr) 2000-06-14 2001-06-14 Inhibiteurs de proteases

Publications (1)

Publication Number Publication Date
AP2002002671A0 true AP2002002671A0 (en) 2002-12-31

Family

ID=24376433

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002671A AP2002002671A0 (en) 2000-06-14 2001-06-14 Protease inhibitors.

Country Status (25)

Country Link
EP (1) EP1307204A4 (fr)
JP (1) JP2004503502A (fr)
KR (1) KR20030008220A (fr)
CN (1) CN1444481A (fr)
AP (1) AP2002002671A0 (fr)
AR (1) AR032622A1 (fr)
AU (1) AU2001268407A1 (fr)
BG (1) BG107327A (fr)
BR (1) BR0111693A (fr)
CA (1) CA2412353A1 (fr)
CZ (1) CZ20024086A3 (fr)
EA (1) EA200300018A1 (fr)
EC (1) ECSP024388A (fr)
HU (1) HUP0301231A2 (fr)
IL (1) IL153421A0 (fr)
MA (1) MA25758A1 (fr)
MX (1) MXPA02012442A (fr)
NO (1) NO20025786L (fr)
NZ (1) NZ522965A (fr)
OA (1) OA12288A (fr)
PE (1) PE20011374A1 (fr)
PL (1) PL360508A1 (fr)
SK (1) SK17592002A3 (fr)
WO (1) WO2001095911A1 (fr)
ZA (1) ZA200209808B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034159A1 (fr) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Inhibiteurs de protease
WO2001034158A1 (fr) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Inhibiteurs de proteases
KR20040004445A (ko) * 2000-11-22 2004-01-13 스미스클라인 비참 코포레이션 프로테아제 억제제
NZ526883A (en) 2001-02-20 2005-11-25 Chugai Pharmaceutical Co Ltd Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
US7709510B2 (en) 2001-02-20 2010-05-04 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
EP1401453A4 (fr) * 2001-05-17 2005-04-06 Smithkline Beecham Corp Inhibiteurs de protease
GB0220187D0 (en) * 2002-08-30 2002-10-09 Novartis Ag Organic compounds
WO2005037258A2 (fr) 2003-08-01 2005-04-28 Chugai Seiyaku Kabushiki Kaisha Composes azole a base de cyanoguanidine-utilises comme inhibiteurs de malonyl-coa decarboxylase
JP4648317B2 (ja) 2003-08-01 2011-03-09 中外製薬株式会社 マロニル−ＣｏＡデカルボキシラーゼ阻害剤として有用なピペリジン化合物
ATE487475T1 (de) 2003-08-01 2010-11-15 Chugai Pharmaceutical Co Ltd Heterocyclische verbindungen als nützliche malonyl-coa decarboxylase-hemmer
JP5587790B2 (ja) 2008-01-09 2014-09-10 アミュラ セラピューティクス リミティド 化合物
CN103275070A (zh) * 2013-05-10 2013-09-04 郑彪 调节单核细胞增殖的四环化合物及其应用
US9427441B2 (en) 2014-02-19 2016-08-30 Indiana University Research And Technology Corporation Targeting primary cilia to treat glaucoma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ2285A1 (fr) * 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
BR9916488A (pt) * 1998-12-23 2001-10-09 Smithkline Beecham Corp Inibidores de protease
WO2001034158A1 (fr) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Inhibiteurs de proteases
EP1235577A4 (fr) * 1999-11-10 2003-04-09 Smithkline Beecham Corp Inhibiteurs de protease
WO2002017924A1 (fr) * 2000-09-01 2002-03-07 Smithkline Beecham Corporation Procede de traitement
KR20040004445A (ko) * 2000-11-22 2004-01-13 스미스클라인 비참 코포레이션 프로테아제 억제제
EP1401453A4 (fr) * 2001-05-17 2005-04-06 Smithkline Beecham Corp Inhibiteurs de protease

Also Published As

Publication number Publication date
NZ522965A (en) 2004-06-25
NO20025786D0 (no) 2002-12-02
EP1307204A4 (fr) 2004-06-02
CA2412353A1 (fr) 2001-12-20
OA12288A (en) 2003-12-12
ECSP024388A (es) 2003-02-06
WO2001095911A1 (fr) 2001-12-20
BR0111693A (pt) 2004-04-06
KR20030008220A (ko) 2003-01-24
EA200300018A1 (ru) 2003-06-26
CZ20024086A3 (cs) 2003-05-14
MA25758A1 (fr) 2003-04-01
SK17592002A3 (sk) 2003-05-02
BG107327A (bg) 2003-07-31
AU2001268407A1 (en) 2001-12-24
CN1444481A (zh) 2003-09-24
JP2004503502A (ja) 2004-02-05
ZA200209808B (en) 2004-07-09
IL153421A0 (en) 2003-07-06
EP1307204A1 (fr) 2003-05-07
MXPA02012442A (es) 2003-04-25
PE20011374A1 (es) 2002-04-07
PL360508A1 (en) 2004-09-06
HUP0301231A2 (hu) 2003-08-28
AR032622A1 (es) 2003-11-19
NO20025786L (no) 2003-02-12

Similar Documents

Publication Publication Date Title
GC0000178A (en) Protease inhibitors
MY141596A (en) Protease inhibitors
AP9801222A0 (en) Proatease inhibitors.
NZ537853A (en) Inhibitors of cathepsin K and related cysteine protesases of the CA clan
WO1999059526A3 (fr) Inhibiteurs de protease
MXPA02012442A (es) Inhibidores de proteasa.
BR9809333A (pt) Inibidores de proteases
HK1042695A1 (zh) 蛋白酶抑制剂
HK1041690A1 (zh) 蛋白酶抑制剂
WO2002092563A3 (fr) Inhibiteurs de protease
HK1044758A1 (zh) 蛋白酶抑制剂
WO2003053331A3 (fr) Inhibiteurs de la protease
UY26026A1 (es) Inhibidores de proteasas
ECSP992959A (es) Inhibidores de proteasa de bis- aminometil carbonilo
ECSP982486A (es) Inhibidores de proteasas ii
AR021971A1 (es) Inhibidores de proteasas
ECSP003403A (es) Inhibidores de proteasas xi
ECSP993293A (es) Inhibidores de proteasas viii
UY26771A1 (es) Inhibidores de proteasas
ECSP982481A (es) Inhibidores de proteasas
ECSP003353A (es) Inhibidores de proteasas ix
ECSP982493A (es) Inhibidores de proteasas iii
NZ324101A (en) Protease inhibitors, pharmaceutical compositions and use thereof